Disc Medicine (IRON) Notes Payables (2020 - 2021)
Disc Medicine's (IRON) quarterly Notes Payables came in at $6.4 million in Q4 2021, down 44.82% year-on-year from $11.7 million in Q4 2020, and down 44.82% on a QoQ basis from $11.7 million in Q4 2020.
Disc Medicine (IRON) Notes Payables (2020 - 2021) Analysis & Trends
Disc Medicine (IRON) has 2 years of Notes Payables data on file, last reported at $6.4 million in Q4 2021.
- On a quarterly basis, Notes Payables fell 44.82% year-over-year to $6.4 million in Q4 2021; TTM through Dec 2021 was $6.4 million, a 44.82% decrease from a year earlier, with the FY2021 full-year figure at $6.4 million, down 44.82% from the prior year.
- Notes Payables for Q4 2021 stood at $6.4 million, down from $11.7 million in the prior quarter.
- Over the last five years, Notes Payables for IRON reached as high as $11.7 million in Q4 2020 and fell as low as $6.4 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 6.45 Mn |
| Dec 31, 2020 | 11.69 Mn |